Nature Medicine 11, 1214 - 1221 (2005)
Published online: 16 October 2005; Corrected online: 18 October 2005 | doi:10.1038/nm1314
Dopamine covalently modifies and functionally inactivates parkinMatthew J LaVoie, Beth L Ostaszewski, Andreas Weihofen, Michael G Schlossmacher
& Dennis J Selkoe Supplementary Fig. 1 (pdf 224K)
Characterization of the dopaminergic MES cell line and antibodies used. Supplementary Fig. 2 (pdf 292K)
Further examination of dopamine-Parkin interactions and sex, post mortem interval, and age at death of human subjects used in Fig. 4. Supplementary Methods (pdf 48K)
| 
